Scientific Sessions

Pancreatic cancer is a serious disease that requires prompt medical attention. Treatment options depend on the stage of the cancer and may include surgery, chemotherapy, radiation therapy, and targeted therapy. Surgery is the most common treatment option for pancreatic cancer, but it is only possible if the cancer has not spread to other parts of the body. Chemotherapy is often used after surgery to kill any remaining cancer cells. Radiation therapy may also be used to destroy cancer cells or alleviate pain. Targeted therapy is a newer approach that uses drugs to specifically target cancer cells. Treatment for pancreatic cancer can be challenging, and it is important to work closely with your healthcare team to determine the best course of action for your specific situation.

Important links:
Download the brochure of the clinical microbiology conference
Submit abstracts on the above microbiology session
Register for the clinical microbiology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

The microbiome refers to the collection of microorganisms that inhabit the human body, particularly the gut. Recent research has shown that changes in the gut microbiome are associated with the development and progression of inflammatory bowel disease (IBD), a group of disorders characterized by chronic inflammation of the digestive tract. In healthy individuals, the gut microbiome is diverse and balanced, with a large number of beneficial bacteria that help to maintain a healthy digestive system. However, in individuals with IBD, the gut microbiome is often disrupted, with an overgrowth of harmful bacteria and a decrease in beneficial bacteria. This imbalance can lead to inflammation and damage to the intestinal lining. Studies have shown that targeting the microbiome may be a promising strategy for the treatment of IBD. For example, fecal microbiota transplantation (FMT), which involves transferring fecal matter from a healthy donor into the gut of a patient with IBD, has shown promising results in some cases. Additionally, probiotics, prebiotics, and other dietary interventions that promote a healthy gut microbiome have shown some potential in the management of IBD symptoms.

Important links:
Download the brochure of the clinical microbiology conference
Submit abstracts on the above microbiology session
Register for the clinical microbiology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Hepatocellular carcinoma (HCC) is a type of liver cancer that is often diagnosed at an advanced stage and has limited treatment options. However, several therapeutic approaches have shown promise in managing HCC. These include surgical resection, liver transplantation, locoregional therapy, and systemic therapy. Surgical resection and liver transplantation are considered curative therapies for HCC, but they are only possible for patients with early-stage disease and good liver function. Locoregional therapies, such as radiofrequency ablation, transarterial chemoembolization, and radiation therapy, are used to treat tumors that cannot be surgically removed. Systemic therapy, including chemotherapy, targeted therapy, and immunotherapy, may be used to treat advanced HCC that has spread to other parts of the body. In recent years, targeted therapies and immunotherapies have shown particular promise in the treatment of HCC. These therapies target specific molecules or pathways that are involved in the development and progression of HCC and may offer new treatment options for patients with advanced disease. The choice of therapeutic approach for HCC depends on various factors, including the stage of the disease, the patient’s overall health, and the availability of treatment options. A multidisciplinary approach involving a team of specialists is often necessary to determine the most appropriate treatment plan for each individual patient.

Important links:
Download the brochure of the clinical microbiology conference
Submit abstracts on the above microbiology session
Register for the clinical microbiology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Endoscopic imaging refers to the use of an endoscope, a flexible tube with a camera and light source, to visualize the inside of the body. Endoscopic imaging is commonly used for diagnostic and therapeutic purposes in a variety of medical specialties, including gastroenterology, pulmonology, and gynecology. In gastroenterology, endoscopic imaging is used to visualize the esophagus, stomach, and intestines for the diagnosis and management of various gastrointestinal conditions. This may include the detection of ulcers, polyps, tumors, or other abnormalities that may require further investigation or treatment. In pulmonology, endoscopic imaging is used to examine the airways and lungs for the diagnosis and management of respiratory conditions, such as lung cancer, chronic obstructive pulmonary disease (COPD), and asthma. In gynecology, endoscopic imaging is used to visualize the cervix, uterus, and fallopian tubes for the diagnosis and treatment of various gynecological conditions, such as abnormal bleeding, infertility, or tumors. Advancements in endoscopic imaging technology, such as high-definition imaging, narrow-band imaging, and confocal laser endomicroscopy, have improved the accuracy and precision of endoscopic examinations, allowing for earlier detection and treatment of various medical conditions.

Important links:
Download the brochure of the clinical microbiology conference
Submit abstracts on the above microbiology session
Register for the clinical microbiology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Epigenetics refers to the changes in gene expression that occur without changes to the DNA sequence itself. These changes can be influenced by various factors, including environmental factors, lifestyle factors, and aging. Epigenetic changes can have significant effects on the development and progression of cancer. In cancer, epigenetic changes can lead to the activation of oncogenes, which promote cell growth and division, or the inactivation of tumor suppressor genes, which normally prevent abnormal cell growth. These changes can contribute to the development and progression of cancer. Recent research has focused on the development of epigenetic therapies for the treatment of cancer. These therapies aim to reverse the epigenetic changes that have occurred in cancer cells, leading to the reactivation of tumor suppressor genes and the inhibition of oncogene activity. Epigenetic therapies may be used alone or in combination with other treatments, such as chemotherapy or radiation therapy. Examples of epigenetic therapies currently in use or under development include DNA methylation inhibitors, histone deacetylase inhibitors, and inhibitors of enzymes involved in chromatin remodeling. These therapies have shown promising results in the treatment of various types of cancer, including leukemia, lymphoma, and solid tumors. Overall, the study of epigenetics in cancer has provided new insights into the mechanisms of cancer development and progression, and has led to the development of new therapeutic strategies for the treatment of this complex disease.

Important links:
Download the brochure of the clinical microbiology conference
Submit abstracts on the above microbiology session
Register for the clinical microbiology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

In vertebrates, the gallbladder, also known as the cholecystic, is a small hollow organ where bile is stored and concentrated before it is released into the small intestine. In humans, the pear-shaped gallbladder lies beneath the liver, although the structure and position of the gallbladder can vary significantly among animal species. It receives bile, produced by the liver, via the common hepatic duct, and stores it. The bile is then released via the common bile duct into the duodenum, where the bile helps in the digestion of fats.

The gallbladder can be affected by gallstones, formed by material that cannot be dissolved – usually cholesterol or bilirubin, a product of haemoglobin breakdown. These may cause significant pain, particularly in the upper-right corner of the abdomen, and are often treated with removal of the gallbladder (called a cholecystectomy). Cholecystitis, inflammation of the gallbladder, has a wide range of causes, including result from the impaction of gallstones, infection, and autoimmune disease.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the clinical gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

GERD diagnosis typically involves a medical history and physical examination to assess symptoms and signs of inflammation or narrowing of the esophagus. Diagnostic tests such as upper endoscopy, esophageal pH monitoring, esophageal manometry, or a barium swallow may also be used to confirm a diagnosis of GERD. Treatment options include lifestyle changes, medication, and, in some cases, surgery.

Important links:
Download the brochure of the clinical microbiology conference
Submit abstracts on the above microbiology session
Register for the clinical microbiology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Chronic liver disease in the clinical context is a disease process of the liver that involves a process of progressive destruction and regeneration of the liver parenchyma leading to fibrosis and cirrhosis. “Chronic liver disease” refers to disease of the liver which lasts over a period of six months. It consists of a wide range of liver pathologies which include inflammation (chronic hepatitis), liver cirrhosis, and hepatocellular carcinoma. The entire spectrum need not be experienced.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the clinical gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Endoscopy is an important diagnostic and therapeutic tool used in the management of gastrointestinal (GI) diseases. Emerging technologies in endoscopy aim to improve diagnostic accuracy, enhance visualization of lesions, and enable more precise and minimally invasive interventions. One emerging technology is confocal laser endomicroscopy (CLE), which uses a laser and specialized imaging technology to obtain high-resolution images of the mucosal and submucosal layers of the GI tract. CLE has shown promise in improving the detection and characterization of precancerous and cancerous lesions in the esophagus, stomach, and colon. Another emerging technology is virtual chromoendoscopy, which uses computer software to enhance the contrast and visualization of lesions in real-time during endoscopy. This technology has been shown to improve the detection of small polyps and flat lesions in the colon. In addition, advanced endoscopic techniques such as endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) are increasingly being used to remove precancerous and early-stage cancerous lesions from the GI tract with minimal invasiveness. These techniques can help avoid more invasive surgical procedures and improve patient outcomes. Overall, emerging technologies in endoscopy are enabling more precise and effective diagnosis and treatment of GI diseases, leading to better patient outcomes.

Important links:
Download the brochure of the clinical microbiology conference
Submit abstracts on the above microbiology session
Register for the clinical microbiology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Jaundice, also known as icterus, is a yellowish or greenish pigmentation of the skin and sclera due to high bilirubin levels. Jaundice in adults is typically a sign indicating the presence of underlying diseases involving abnormal heme metabolism, liver dysfunction, or biliary-tract obstruction. The prevalence of jaundice in adults is rare, while jaundice in babies is common, with an estimated 80% affected during their first week of life. The most commonly associated symptoms of jaundice are itchiness, pale feces, and dark urine

Important links:
Download the brochure of the clinical gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the clinical gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Peptic ulcer disease is when the inner part of the stomach’s gastric mucosa (lining of the stomach), the first part of the small intestine, or sometimes the lower esophagus, gets damaged. An ulcer in the stomach is called a gastric ulcer, while one in the first part of the intestines is a duodenal ulcer. The most common symptoms of a duodenal ulcer are waking at night with upper abdominal pain, and upper abdominal pain that improves with eating. With a gastric ulcer, the pain may worsen with eating. The pain is often described as a burning or dull ache. Other symptoms include belching, vomiting, weight loss, or poor appetite. About a third of older people with peptic ulcers have no symptoms. Complications may include bleeding, perforation, and blockage of the stomach. Bleeding occurs in as many as 15% of cases.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Inflammatory bowel disease (IBD) is a chronic autoimmune condition characterized by inflammation of the gastrointestinal tract. While current treatments for IBD, including anti-inflammatory medications and immunosuppressive drugs, can be effective, they often have significant side effects and are not always effective for all patients. As a result, there is a need for novel IBD treatments that can provide better outcomes for patients. One promising area of research in IBD is the development of biologic therapies that target specific molecules involved in the inflammatory process. These include drugs that target cytokines such as interleukin-23 (IL-23), which has been implicated in the pathogenesis of Crohn’s disease, and antibodies that block the migration of white blood cells into the inflamed gut tissue. Another area of research in IBD is the use of fecal microbiota transplantation (FMT) to restore the balance of gut bacteria. FMT involves transferring fecal matter from a healthy donor into the gastrointestinal tract of a patient with IBD. While the exact mechanism of action is not yet fully understood, FMT has shown promising results in clinical trials, particularly in patients with recurrent C. difficile infection and ulcerative colitis. Other emerging therapies for IBD include novel small molecule drugs, stem cell therapy, and gene therapy. These treatments are still in the early stages of development, but early studies have shown promising results. Overall, while current treatments for IBD can be effective, there is a need for novel therapies that can provide better outcomes for patients. Biologic therapies, FMT, and other emerging treatments offer hope for more effective and targeted therapies for this challenging condition.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Gastrointestinal (GI) surgery is a broad field that encompasses a wide range of surgical procedures, from minimally invasive laparoscopic surgeries to major open surgeries. The goal of GI surgery is to treat a variety of conditions, including cancer, inflammatory bowel disease, and functional disorders. One strategy in GI surgery is to use minimally invasive techniques whenever possible. Minimally invasive surgery, which includes laparoscopic and robotic-assisted procedures, involves making small incisions and using specialized instruments and cameras to perform the surgery. These techniques can lead to less pain and scarring, faster recovery times, and lower rates of complications compared to traditional open surgery. Another strategy in GI surgery is to use a multidisciplinary approach, involving a team of specialists from different fields such as gastroenterology, radiology, and oncology. This approach can help ensure that patients receive the most appropriate treatment plan and optimize their outcomes. In addition, surgical innovations such as enhanced recovery after surgery (ERAS) protocols and 3D printing have the potential to further improve outcomes in GI surgery. ERAS protocols involve a coordinated approach to care that includes optimizing nutrition, minimizing opioid use, and early mobilization after surgery. 3D printing can be used to create patient-specific models that can help surgeons plan and perform complex surgeries with greater precision. Overall, strategies in GI surgery include using minimally invasive techniques, a multidisciplinary approach, and innovative technologies and protocols to optimize outcomes for patients.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

A gallstone is a stone formed within the gallbladder from precipitated bile components. The term cholelithiasis may refer to the presence of gallstones or to any disease caused by gallstones, and choledocholithiasis refers to the presence of migrated gallstones within bile ducts.

Most people with gallstones (about 80%) are asymptomatic. However, when a gallstone obstructs the bile duct and causes acute cholestasis, a reflexive smooth muscle spasm often occurs, resulting in an intense cramp-like visceral pain in the right upper part of the abdomen known as a biliary colic (or “gallbladder attack”).This happens in 1–4% of those with gallstones each year. Complications from gallstones may include inflammation of the gallbladder (cholecystitis), inflammation of the pancreas (pancreatitis), obstructive jaundice, and infection in bile ducts (cholangitis).Symptoms of these complications may include pain that lasts longer than five hours, fever, yellowish skin, vomiting, dark urine, and pale stools.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Celiac disease is a genetic autoimmune disorder in which the ingestion of gluten triggers an immune response that damages the small intestine. Gluten is a protein found in wheat, barley, and rye. When a person with celiac disease eats foods containing gluten, their immune system reacts by damaging the small intestine, which can lead to a range of symptoms, including abdominal pain, diarrhea, bloating, fatigue, and malnutrition. Diagnosis of celiac disease involves a blood test that measures certain antibodies that are present in people with the disease. If the blood test is positive, a biopsy of the small intestine may be performed to confirm the diagnosis. The primary treatment for celiac disease is a strict gluten-free diet, which involves avoiding all foods that contain wheat, barley, and rye. This can be challenging, as gluten can be found in many processed foods, including bread, pasta, and baked goods. However, with proper education and support, most people with celiac disease are able to successfully manage their condition through diet. In addition to a gluten-free diet, people with celiac disease may also benefit from supplements to correct nutrient deficiencies caused by malabsorption, as well as follow-up care with a gastroenterologist to monitor for potential complications of the disease, such as osteoporosis and anemia. Overall, celiac disease is a chronic autoimmune disorder that requires lifelong management through strict adherence to a gluten-free diet. With proper diagnosis and treatment, however, most people with celiac disease are able to lead healthy and active lives.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Clostridioides difficile infection (CDI) is a bacterial infection that can cause severe symptoms such as diarrhea, fever, and abdominal pain. CDI is most commonly seen in people who have been taking antibiotics, as antibiotics can disrupt the natural balance of bacteria in the gut and allow C. difficile to overgrow. CDI can also occur in healthcare settings, as it is highly contagious and can spread easily from person to person. The primary treatment for CDI is antibiotics, such as metronidazole or vancomycin, which are effective in most cases. However, the use of antibiotics can also increase the risk of recurrence and can further disrupt the natural balance of bacteria in the gut. Therefore, in addition to antibiotics, management strategies such as probiotics and fecal microbiota transplantation (FMT) have also been shown to be effective in reducing the risk of recurrence and improving outcomes in people with CDI. Probiotics, such as Lactobacillus, Bifidobacterium, and Saccharomyces boulardii, can help to restore the natural balance of bacteria in the gut and reduce the risk of CDI recurrence. FMT involves transplanting stool from a healthy donor into the gut of a person with CDI, in order to restore the natural balance of bacteria in the gut and reduce the risk of recurrence. FMT has been shown to be highly effective in the treatment of recurrent CDI, and is now considered a standard of care in many healthcare settings.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Biliary tract cancer (BTC) is a rare and aggressive cancer that affects the bile ducts, which are the tubes that carry bile from the liver to the small intestine. The treatment of BTC depends on several factors, including the location and extent of the cancer, as well as the overall health of the patient. Surgery is the primary treatment for early-stage BTC and may involve the removal of a portion of the liver or bile ducts. However, many people with BTC are not candidates for surgery, as the cancer is often diagnosed at an advanced stage. In these cases, treatment may involve chemotherapy, radiation therapy, or a combination of both. Newer therapies, such as immunotherapy and targeted therapy, are also being studied for the treatment of BTC. Immunotherapy involves using drugs to boost the body’s immune system and help it to recognize and attack cancer cells. Targeted therapy involves using drugs that target specific molecules that are involved in the growth and spread of cancer cells. Despite these advances, the prognosis for BTC remains poor, with a 5-year survival rate of less than 10%. However, early detection and treatment can improve outcomes and quality of life for people with BTC, highlighting the importance of ongoing research and development of new therapies for this challenging cancer.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Barrett’s esophagus is a condition where the cells lining the esophagus change and become more similar to cells in the small intestine. This change is believed to be a response to long-term exposure to stomach acid, typically as a result of gastroesophageal reflux disease (GERD). Barrett’s esophagus can increase the risk of developing esophageal cancer, which is a serious and potentially deadly cancer. The diagnosis of Barrett’s esophagus is made through an upper endoscopy, where a doctor will examine the esophagus using a small camera attached to a flexible tube. If Barrett’s esophagus is suspected, a biopsy may be taken to confirm the diagnosis. The treatment of Barrett’s esophagus depends on the extent of the changes in the cells and the presence of dysplasia, which is an abnormal growth of cells that can indicate an increased risk of cancer. For people with no or low-grade dysplasia, treatment may involve regular endoscopic surveillance to monitor for changes. For people with high-grade dysplasia, treatment may involve endoscopic therapy, such as radiofrequency ablation or endoscopic mucosal resection, to remove the affected tissue. The management of Barrett’s esophagus also involves addressing the underlying GERD, which can include lifestyle modifications and medications to reduce the amount of stomach acid that refluxes into the esophagus. Proper management of Barrett’s esophagus can help to reduce the risk of developing esophageal cancer and improve outcomes for people with this condition.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Liver transplantation is a surgical procedure where a diseased or damaged liver is replaced with a healthy liver from a donor. This procedure is typically reserved for people with end-stage liver disease or liver failure, as well as certain liver cancers. The process of liver transplantation involves an extensive evaluation process to determine if the person is a suitable candidate for the procedure. This includes a comprehensive medical and psychosocial evaluation, as well as tests to assess the liver’s function and the person’s overall health. Once a suitable donor liver becomes available, the person will undergo the transplant surgery, which typically takes several hours. After the surgery, the person will require close monitoring and may stay in the hospital for several days or weeks, depending on their condition. The success of liver transplantation depends on several factors, including the underlying cause of the liver disease, the extent of liver damage, and the person’s overall health. With proper post-transplant care, including medications to prevent rejection of the new liver, many people are able to return to a normal, healthy life following a liver transplant. However, ongoing monitoring and care are required to ensure the long-term success of the transplant and prevent complications.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Steatohepatitis is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. Mere deposition of fat in the liver is termed steatosis, and together these constitute fatty liver changes.

There are 2 main types of fatty liver disease (FLD):

Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) (previously non-alcoholic fatty liver disease or NAFLD)

Alcohol-associated (Alcohol-related) Liver Disease (ALD)

Risk factors for MASLD include diabetes, obesity and metabolic syndrome. When inflammation is present it is referred to as alcoholic steatohepatitis and non alcoholic (metabolic dysfunction associated) steatohepatitis (MASH, previously NASH). Steatohepatitis of either cause may progress to cirrhosis, and MASH is now believed to be a frequent cause of unexplained cirrhosis (at least in Western societies). MASH is also associated with lysosomal acid lipase deficiency.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Colorectal cancer (CRC) is a type of cancer that develops in the colon or rectum. In recent years, there have been significant advances in the diagnosis and treatment of CRC, which have led to improved outcomes for many people with this disease. One major advance in CRC diagnosis is the use of screening tests, such as colonoscopies, that can detect precancerous polyps before they become cancerous. Early detection through screening has been shown to significantly reduce the risk of developing advanced CRC and improve survival rates. In terms of treatment, there are now several options available for people with CRC, including surgery, radiation therapy, chemotherapy, and targeted therapy. Newer treatments, such as immunotherapy and combination therapies, are also being developed and tested in clinical trials. Furthermore, advances in genetics and genomics have led to a better understanding of the molecular pathways involved in CRC development and progression. This has led to the development of targeted therapies that can specifically target these pathways, leading to more effective treatment options for people with CRC. Overall, these advances in diagnosis, treatment, and research are improving the outlook for people with CRC and bringing us closer to the goal of preventing and curing this disease.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Environmental factors can play an important role in the development and progression of various gastrointestinal (GI) disorders. For example, diet and lifestyle factors have been linked to an increased risk of developing conditions such as colorectal cancer, inflammatory bowel disease (IBD), and gastroesophageal reflux disease (GERD). Studies have also suggested that exposure to environmental toxins, such as pesticides, may increase the risk of developing certain GI disorders. For example, some studies have found a link between pesticide exposure and an increased risk of developing colon cancer. Additionally, changes in environmental factors, such as climate change and shifts in microbial populations, may also impact the development and progression of GI disorders. For example, changes in temperature and precipitation patterns can affect the distribution of infectious agents that cause GI infections, while shifts in microbial populations in the gut may impact the development and progression of conditions such as IBD. Overall, understanding the role of environmental factors in the development and progression of GI disorders is an important area of research that can lead to the development of new prevention and treatment strategies for these conditions.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Hepatitis is a condition characterized by inflammation of the liver, usually caused by a viral infection. Diagnosis of hepatitis typically involves a combination of clinical assessment, laboratory tests, and imaging studies. The first step in diagnosing hepatitis is a thorough medical history and physical examination. Your healthcare provider may ask about your symptoms, medical history, and any risk factors you may have for hepatitis, such as intravenous drug use or unprotected sex. Blood tests are also commonly used to diagnose hepatitis. These tests can detect the presence of specific antibodies and antigens associated with different types of viral hepatitis, such as hepatitis A, B, or C. Blood tests can also assess liver function and detect any signs of liver damage. In some cases, imaging studies, such as an ultrasound or CT scan, may be used to evaluate the liver and identify any abnormalities or damage. If hepatitis is suspected, further diagnostic tests may be needed to determine the underlying cause of the infection and the best treatment approach. Treatment for hepatitis may involve antiviral medications, lifestyle changes, and supportive care to manage symptoms and prevent complications.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Chronic pancreatitis is a condition characterized by inflammation of the pancreas that persists over a long period of time. The management of chronic pancreatitis typically involves a combination of lifestyle modifications, medication, and in some cases, surgery. Lifestyle modifications can include changes to diet and alcohol consumption, which can help to reduce inflammation and prevent further damage to the pancreas. Your healthcare provider may recommend a low-fat, high-fiber diet and may advise you to avoid alcohol and tobacco use. Medications used to manage chronic pancreatitis may include pain relievers, pancreatic enzyme supplements to aid digestion, and medications to reduce inflammation. Your healthcare provider may also recommend the use of insulin or other medications to manage any diabetes that may have developed as a result of the pancreatitis. In some cases, surgery may be needed to manage chronic pancreatitis. This may involve removing any obstructions or damaged tissue in the pancreas, or procedures to relieve pressure on the pancreas and reduce inflammation. Overall, the management of chronic pancreatitis is focused on reducing inflammation, managing pain and other symptoms, and preventing complications. Your healthcare provider can work with you to develop a personalized treatment plan that addresses your specific symptoms and needs.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Autoimmune diseases are a group of disorders characterized by an abnormal immune response against the body’s own tissues and organs. Several autoimmune diseases can affect the gastrointestinal (GI) tract, including celiac disease, inflammatory bowel disease (IBD), and autoimmune hepatitis. Celiac disease is an autoimmune disorder in which the immune system mistakenly attacks the lining of the small intestine in response to gluten, a protein found in wheat, barley, and rye. This can lead to inflammation and damage to the small intestine, causing symptoms such as abdominal pain, diarrhea, and weight loss. Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the GI tract that includes Crohn’s disease and ulcerative colitis. In IBD, the immune system attacks the lining of the GI tract, leading to inflammation and damage to the tissue. This can cause a range of symptoms, including abdominal pain, diarrhea, and rectal bleeding. Autoimmune hepatitis is a chronic liver disease in which the immune system attacks the liver, leading to inflammation and damage to the tissue. This can cause a range of symptoms, including fatigue, abdominal pain, and jaundice. The treatment of autoimmune diseases that affect the GI tract typically involves medications to reduce inflammation and manage symptoms, as well as dietary changes and lifestyle modifications to promote overall health and well-being. In some cases, surgery may be needed to manage complications or relieve symptoms. Your healthcare provider can work with you to develop a personalized treatment plan that addresses your specific symptoms and needs.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that affects the large intestine. It is characterized by a group of symptoms, including abdominal pain, bloating, and changes in bowel habits, such as diarrhea or constipation. While the exact cause of IBS is not yet fully understood, new research has shed light on some potential contributing factors. One emerging theory is that IBS may be linked to alterations in the gut microbiome, the collection of bacteria and other microorganisms that inhabit the gastrointestinal tract. Studies have found that people with IBS may have a different balance of gut bacteria than those without the condition, and that certain types of bacteria may be more prevalent in people with IBS. Other research has suggested that IBS may be related to abnormalities in the way the brain and gut communicate with each other, known as the gut-brain axis. This could help to explain why stress and anxiety can trigger or worsen IBS symptoms in some people. New treatments and management strategies are also being developed for IBS. For example, some studies have shown that a low-FODMAP diet, which restricts certain types of carbohydrates that can be difficult to digest, may help to alleviate symptoms in some people with IBS. There are also a variety of medications, including antispasmodics and antidepressants, that can be used to manage symptoms. Overall, while much remains to be learned about IBS, new insights into the condition are helping to improve our understanding of its underlying causes and develop new approaches to treatment and management.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Acute pancreatitis is a sudden inflammation of the pancreas, a gland located behind the stomach that produces digestive enzymes and hormones. The condition can be life-threatening, especially if it leads to complications such as pancreatic necrosis, sepsis, or multiple organ failure. The management of acute pancreatitis typically involves supportive care to relieve symptoms and prevent complications. This may include hospitalization, fasting to rest the pancreas, intravenous fluids to prevent dehydration, and pain medication to manage abdominal pain. In severe cases, patients may require enteral or parenteral nutrition, which involves providing nutrients through a feeding tube or intravenously to support the healing process. Antibiotics may also be prescribed to prevent or treat infections. In cases of pancreatic necrosis, surgery or minimally invasive procedures such as endoscopic necrosectomy may be necessary to remove dead tissue and prevent further complications.To prevent future episodes of acute pancreatitis, patients may need to make lifestyle changes such as avoiding alcohol and high-fat foods, managing underlying conditions such as gallstones or high triglycerides, and taking medications as prescribed. Overall, the management of acute pancreatitis requires a multidisciplinary approach and close monitoring of the patient’s condition to ensure the best possible outcomes.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Tissue engineering is a rapidly evolving field that involves the development of biological constructs to repair or replace damaged or diseased tissues or organs. While the application of tissue engineering to the gastrointestinal (GI) tract is still in the early stages of development, there is growing interest in the potential of this approach to address a range of GI conditions. One area of focus in GI tissue engineering is the development of biomaterials to repair or replace damaged tissue in the esophagus, stomach, intestine, or colon. This can involve the use of natural or synthetic materials, such as hydrogels or scaffolds, that can support the growth and differentiation of cells. Another approach is to use stem cells to regenerate damaged tissues, either by transplanting cells into the body or by developing engineered tissues in the lab for later transplantation. Stem cells can be obtained from a variety of sources, including the patient’s own tissues or from donated tissues. In addition, tissue engineering is being explored as a potential means of developing functional organs for transplantation, such as a bioengineered liver or pancreas. While these applications are still in the experimental stage, they hold promise for addressing the shortage of donor organs and improving outcomes for patients with end-stage GI diseases. Overall, tissue engineering is an exciting area of research in GI medicine, with the potential to revolutionize the diagnosis and treatment of a wide range of conditions.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterology session
Register for the clinical microbiology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Gastrointestinal (GI) bleeding can occur in any part of the digestive tract, from the esophagus to the rectum, and can range from mild to severe, requiring urgent medical attention. The diagnosis and management of GI bleeding typically involves a multidisciplinary approach and depends on the underlying cause and severity of the bleeding. Diagnostic tests for GI bleeding may include upper or lower endoscopy, imaging studies such as CT or angiography, or blood tests to check for anemia or clotting disorders. In some cases, capsule endoscopy or double-balloon enteroscopy may be needed to evaluate bleeding in the small intestine. Once the source and severity of the bleeding are identified, management may involve a variety of interventions, ranging from conservative measures to surgical intervention. Conservative measures may include blood transfusions, intravenous fluids, or medications to control bleeding, such as proton pump inhibitors or octreotide. Endoscopic interventions, such as injection therapy, thermal therapy, or endoscopic hemostasis, may be used to treat bleeding from ulcers, varices, or other lesions in the GI tract. Interventional radiology techniques, such as embolization or stenting, may be used to treat bleeding from arteries or veins. In cases of severe or refractory bleeding, surgery may be necessary to stop the bleeding or remove the affected tissue. In some cases, a minimally invasive approach such as laparoscopy may be used. Overall, the management of GI bleeding requires a careful assessment of the underlying cause and severity of the bleeding, as well as close monitoring of the patient’s condition to ensure the best possible outcomes.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterologysession
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram

Gastric cancer is a common malignancy that is often diagnosed at an advanced stage, making treatment challenging. However, recent advances in cancer therapies offer new hope for patients with gastric cancer. Immunotherapy is a promising approach that uses the body’s immune system to fight cancer. Immune checkpoint inhibitors, such as pembrolizumab and nivolumab, have shown promising results in clinical trials for the treatment of advanced gastric cancer. Targeted therapies are another area of emerging therapies for gastric cancer. Trastuzumab, a monoclonal antibody that targets the HER2 receptor, has been shown to improve survival in patients with HER2-positive gastric cancer. Other targeted therapies that are being studied include tyrosine kinase inhibitors and angiogenesis inhibitors. In addition, combination therapies that use chemotherapy, targeted therapies, and immunotherapy are being investigated as potential treatments for gastric cancer. Early clinical trials have shown promising results with these approaches, and more research is needed to determine the optimal treatment strategies. Overall, the emergence of new therapies for gastric cancer provides hope for patients with this challenging malignancy. As research continues to advance, the outlook for patients with gastric cancer is expected to improve.

Important links:
Download the brochure of the gastroenterology conference
Submit abstracts on the above gastroenterologysession
Register for the gastroenterology conference

Like, share, follow our social media pages, and stay updated:
LinkedIn | Facebook | Twitter | YouTube | Instagram